A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine
Clinical trial NCT05164172 · RECRUITING
Trial details
- NCT number
- NCT05164172
- Sponsor
- H. Lundbeck A/S
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-01
- Primary completion
- 2028-04-30
- Enrollment
- 600
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.